BioSpace News Archive

Utilizing Lateral Flow Technology, the “COVID CleanPass by Apollo Medco” Testing System Processes 200-300 People Per Hour While Reporting Results Within 15 Minutes

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of 18 abstracts spanning the company’s HIV treatment and prevention and COVID-19 clinical development programs during the virtual IDWeek 2020 conference from October 21-25. The breadth of data reflects Gilead’s commitment to advancing antiviral innovation aiming to help end the HIV epidemic and to addressing the treatment needs of patients with COV

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise, today announces successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation (HKSE:1548) (“GenScript”), a leading global biotechnology company. The assay targets on coronavirus-specific nanobodies and tests affinity and efficacy to prevent the

SyntheticMR welcomes Dr Fritz to their Medical Advisory Board to support their product management with clinical expertise.

Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it will present five abstracts at the American Society of Nephrology (ASN) Kidney Week 2020, which is being held virtually from October 22-25, 2020. The abstracts will highlight clinical and nonclinical data from novel drug formulations being developed for the treatment of chronic kidney disease (CKD), acute kidney injury (AKI), and COVID-19. The selected a

New Peer-Reviewed Study Substantiates Use Of Photoplethysmography-Based (PPG) Device To Help Accurately Monitor Patient Vitals, Even During Significant Hemodynamic Changes

Neurelis, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted extended expiration dating for the company’s lead product, VALTOCO ® (diazepam nasal spray). VALTOCO was approved by the FDA on January 10, 2020 , for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, s

- Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina , and worldwide headquarters and manufacturing facilities in Elstree, UK, has been reco

Integrated Defense and Security Solutions (IDSS) announced that its advanced computed tomography (CT) checkpoint scanner, the DETECT™ 1000, is the first scanner to achieve the Advanced Passenger Security Screening (APSS) Level 1 certification.

Beyond Air, Inc. announced additional preclinical data that further suggest endogenous high concentration gNO administered directly to solid tumors may trigger a systemic anti-tumor immune response, a concept that could serve as the basis for an effective immunotherapy.